---

$14.20

+0.2500 ( +2.23% ) 211.9K

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-13	Sale	-11336.00	KANOVSKY STEPHEN M
2024-08-13	Sale	-11336.00	HANNAH ALISON L.
2024-08-13	Sale	-11336.00	Zook Anthony P.
2024-08-13	Sale	-11336.00	TETRAULT LYNN A.
2024-08-13	Sale	-11336.00	Floegel Elizabeth
2024-08-13	Sale	-11336.00	Kelly Michael Aaron
2024-08-13	Sale	-11336.00	Gunn Neil
2024-08-13	Sale	-11336.00	Perez David Brian
2024-08-05	Sale	-14.00	Olivo Alicia C
2024-06-04	Sale	-8672.00	Zook Anthony P.

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.